# Quarterly Activities/Appendix 4C Cash Flow Report
Canonical URL: https://biopharmsignal.com/news/MESO/quarterly-activities-appendix-4c-cash-flow-report
Ticker: MESO
Company: Mesoblast
Source: Mesoblast
Published: 2026-04-29 23:56 EST
Original Source URL: https://investorsmedia.mesoblast.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-02 01:51 EST — [ASX CEO Connect Presentation](https://biopharmsignal.com/news/MESO/asx-ceo-connect-presentation) — Source: Mesoblast
- 2026-04-29 23:56 EST — [Quarterly Activities/Appendix 4C Cash Flow Report](https://biopharmsignal.com/news/MESO/quarterly-activities-appendix-4c-cash-flow-report) — Source: Mesoblast
- 2026-04-28 23:50 EST — [Patient Recruitment Target Achieved in CLBP Pivotal Trial](https://biopharmsignal.com/news/MESO/patient-recruitment-target-achieved-in-clbp-pivotal-trial) — Source: Mesoblast
- 2026-04-16 07:22 EST — [Appendix 3Y for Gregory George](https://biopharmsignal.com/news/MESO/appendix-3y-for-gregory-george) — Source: Mesoblast
- 2026-04-16 07:13 EST — [Notification of cessation of securities - MSB](https://biopharmsignal.com/news/MESO/notification-of-cessation-of-securities-msb) — Source: Mesoblast
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)